Myburgh D P
S Afr Med J. 1978 Apr 1;53(13):499-501.
The effectiveness of perhexiline maleate in the suppression of ventricular ectopic activity has been studied in 10 patients after myocardial infarction. Before treatment all patients exhibited frequent ectopic beats, i.e. more than 8 per hour. Numerous Holter magnetic tape recordings were made over a 9 - 10-month period of treatment. During the entire period of monitoring significant suppression of ectopic activity was observed in 5 patients and transient suppression in 4, of whom 3 subsequently showed a transient increase. The drug was discontinued in 1 patient because of nausea, anorexia and weight loss. No other adverse effects were encountered.
已对10例心肌梗死后患者研究了马来酸哌克昔林抑制室性异位活动的有效性。治疗前,所有患者均表现出频发异位搏动,即每小时超过8次。在9至10个月的治疗期间进行了多次动态心电图磁带记录。在整个监测期间,5例患者的异位活动得到显著抑制,4例患者出现短暂抑制,其中3例随后出现短暂增加。1例患者因恶心、厌食和体重减轻而停药。未发现其他不良反应。